Variable |
HFCWO group (n=75) |
Control group (n=82) |
χ2/t |
P |
Effective rate(n, %) |
66,88 |
62, 75.6 |
4.69 |
0.03 |
Fever duration (days) |
3.6±0.93 |
5.1±1.08 |
9.49 |
<0.001 |
Convulsive cough duration (days) |
5.2±1.2 |
5.8±1.5 |
19.62 |
<0.001 |
FEV1 (%) |
81.5±1.67% |
80.3±2.19% |
-3.79 |
<0.001 |
FVC (%) |
85.3±2.49% |
84.2±2.67% |
-2.76 |
0.007 |
PEF (%) |
85.5±1.34% |
84.0±1.05% |
-7.62 |
<0.001 |
WBC(109/L) |
6.30±1.52 |
6.35±1.02 |
0.215 |
0.83 |
CRP(mg/L) |
7.13±4.39 |
9.53±1.51 |
2.501 |
0.013 |
Respiratory rate(times/min) |
18.95±2.84 |
19.78±3.09 |
1.755 |
0.081 |
High respiration
rate(n, %) |
8,10.1 |
19,23.2 |
4.301 |
0.038 |
Oxygen therapy (n, %) |
5,6.67 |
14,17.07 |
4.694 |
0.03 |
LOS(days) |
9.03±1.81 |
10.78±2.49 |
5.01 |
<0.001 |
Treatment cost(Yuan/¥) |
6263.29±1727.7 |
7769.82±2118.65 |
4.856 |
<0.001 |